The ACES Act of 2025 directs the Secretary of Veterans Affairs to arrange for the National Academies of Sciences, Engineering, and Medicine to study cancer prevalence and mortality among certain former military aircrew members. The study must examine exposures tied to fixed-wing aircrew service, review scientific literature on links between those exposures and cancer outcomes, and assess the prevalence and mortality of specified cancers, including brain, colon and rectal, kidney, lung, melanoma, non-Hodgkin lymphoma, pancreatic, prostate, testicular, thyroid, and bladder cancers, as well as other cancers deemed appropriate.
The bill also requires the study to use available federal and other data sources, such as VA and Department of Defense databases, the National Death Index, and prior research conducted under the FY2021 National Defense Authorization Act. Once completed, the National Academies must report its findings to the VA Secretary and the House and Senate Veterans’ Affairs Committees. The act defines covered individuals as active-duty Army, Navy, Air Force, or Marine Corps fixed-wing aircrew members, including pilots and other crew who regularly flew in fixed-wing aircraft.
This law does not directly create new benefits or compensation rules, but it does impose a mandatory research and reporting obligation on the Department of Veterans Affairs. It requires VA to initiate and finalize an agreement with the National Academies on a short timeline and to provide periodic updates to Congress if the agreement is delayed. The resulting study may inform future veterans’ health policy, presumptive service-connection decisions, or additional legislation concerning cancer-related claims and occupational exposures among aircrew veterans.
The available legislative history suggests the bill moved with broad support and little visible opposition, passing both chambers and becoming Public Law 119-32. Because no committee transcripts or recorded votes were provided, there is no evidence of significant debate in the supplied materials. The overall sentiment appears favorable, reflecting bipartisan interest in investigating possible service-related cancer risks for veterans who served as aircrew.
The main substantive issue in the bill is not whether to study the problem, but how broadly to define the exposures and cancers to be examined and how to use existing data sources to produce meaningful findings. Any potential contention would likely center on the scope of the study, the reliability of available data, and whether the findings should lead to broader VA policy changes or presumptive benefits. In the provided record, however, no specific objections or opposing viewpoints are documented.